STATEMENTS OF CHANGES IN EQUITY
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2013
Attributable to owners of the Company
Share
capital
Employee
share
option
reserve
Other
reserves
Treasury
shares
(Note 28)
Accumulated
losses
Total share
capital and
reserves
Non-
controlling
interests
Total
equity
$
$
$
$
$
$
$
$
Group
Balance at 1 January 2012
21,550,530
43,930
–
(1,250)
(7,919,181)
13,674,029 (265,082)
13,408,947
Profit for the year
–
–
–
–
79,613
79,613
(45,690)
33,923
Other comprehensive income
– Foreign currency translation
–
–
(36,416)
–
–
(36,416)
–
(36,416)
Total comprehensive income
for the year
–
–
(36,416)
–
79,613
43,197
(45,690)
(2,493)
Expiry of employee share
options
–
(43,930)
–
–
43,930
–
–
–
Purchase of treasury shares
–
–
–
(1,616)
–
(1,616)
–
(1,616)
Balance at 31 December 2012
and 1 January 2013
21,550,530
–
(36,416)
(2,866)
(7,795,638)
13,715,610 (310,772)
13,404,838
Profit for the year
–
–
–
–
53,946
53,946
10,708
64,654
Other comprehensive income
– Foreign currency translation
–
–
58,774
–
–
58,774
–
58,774
Total comprehensive income
for the year
–
–
58,774
–
53,946
112,720
10,708
123,428
Acquisition of subsidiary and
business
–
–
–
–
–
–
23
23
Shares issued for acquisition
of a business
399,997
–
–
–
–
399,997
–
399,997
Put options granted to
non-controlling interests
(Note 26)
–
–
(652,544)
–
–
(652,544)
–
(652,544)
Balance at 31 December 2013 21,950,527
–
(630,186)
(2,866)
(7,741,692)
13,575,783 (300,041)
13,275,742
ASIAMEDIC LIMITED
ANNUAL REPORT 2013
38